Zobrazeno 1 - 10
of 278
pro vyhledávání: '"R, Sankila"'
Autor:
R Sankila, Lars Klaeboe, C. Johansen, Joachim Schüz, Maria Feychting, Anssi Auvinen, Suvi Larjavaara
Publikováno v:
British Journal of Cancer
Background: The reported incidence rates of vestibular schwannomas (VS) vary substantially, but it is unclear as to what extent the variation reflects differences in risk or recording practices. Our aim was to describe the incidence rates of VS in De
Autor:
Stig Nordling, G Klöppel, Caj Haglund, Eero Pukkala, J Lüttges, Monika Carpelan-Holmström, R Sankila
Publikováno v:
Gut. 54:385-387
Background: Worldwide survival data for ductal adenocarcinoma of the pancreas are the lowest among the 60 most frequent types of organ cancers. Hence published data on long time survivors of this disease are controversial. We performed a nationwide s
Publikováno v:
British Journal of Oral and Maxillofacial Surgery. 29:223-229
Cancers of the mandibular region show the lowest survival rates of all oral cancers. In order to compare the effect of five different modes of treatment (including surgery and/or radiotherapy), a series of 159 patients was analysed. When adjustments
Autor:
R Sankila
Publikováno v:
European Journal of Cancer.
Autor:
N, Paunu, K, Syrjäkoski, R, Sankila, K O, Simola, P, Helén, M, Niemelä, M, Matikainen, J, Isola, H, Haapasalo
Publikováno v:
Journal of neuro-oncology. 55(3)
The high incidence of gliomas in Li-Fraumeni families and the high frequency of somatic p53 mutations in sporadic glial tumors have raised the possibility that germline p53 mutations could play an important role in familial aggregation of gliomas. In
Autor:
R, Sankila
Publikováno v:
Duodecim; laaketieteellinen aikakauskirja. 22(114)
Publikováno v:
Cancer causescontrol : CCC. 12(8)
To compare the risk of cancer between BRCA1 or BRCA2 mutation-positive and -negative families.We assessed standardized incidence ratios (SIR) in 107 Finnish breast cancer families (12 BRCA1, 11 BRCA2, 84 non-BRCA1/2) with confirmed genealogy. The obs
Autor:
M P, Matikaine, E, Pukkala, J, Schleutker, T L, Tammela, P, Koivisto, R, Sankila, O P, Kallioniemi
Publikováno v:
Cancer causescontrol : CCC. 12(3)
Five to ten percent of prostate cancers may be caused by inherited genetic defects. In order to explore the nature of inherited cancer risks in the genetically homogeneous Finnish population, we investigated the incidence of prostate cancer and other
Autor:
J, Schleutker, M, Matikainen, J, Smith, P, Koivisto, A, Baffoe-Bonnie, T, Kainu, E, Gillanders, R, Sankila, E, Pukkala, J, Carpten, D, Stephan, T, Tammela, M, Brownstein, J, Bailey-Wilson, J, Trent, O P, Kallioniemi
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(12)
Several predisposition loci for hereditary prostate cancer (HPC) have been suggested, including HPC1 at 1q24-q25 (OMIM #601518) and HPCX at Xq27-q28 (OMIM #300147). Genetically homogeneous populations, such as that of Finland, and distinct subsets of
Autor:
S, Garwicz, H, Anderson, J H, Olsen, H, Døllner, H, Hertz, G, Jonmundsson, F, Langmark, M, Lanning, T, Möller, R, Sankila, H, Tulinius
Publikováno v:
International journal of cancer. 88(4)
Our purpose was to assess the risk of developing a second malignant neoplasm (SMN) after cancer in childhood and adolescence associated with different treatment modalities. Our investigation was performed as a nested case-control study within a Nordi